Niels Riedemann, MD

Riedemann is CEO of InflaRX.

Articles by Niels Riedemann, MD

Cautionary Tale Associated in Trial With Rare Error in Cox Regression

March 6th 2025

InflaRx CEO Niels Riedemann, MD, discusses the issue that arose and cost the company some of its data for its investigational therapy being studied for SARS-CoV-2-induced acute respiratory distress syndrome (ARDS).

Niels Riedemann, MD

Articles by Niels Riedemann, MD

Cautionary Tale Associated in Trial With Rare Error in Cox Regression

Latest Updated Articles

Trending on Contagion Live

Pandemic Disrupted Antiviral Prescribing for Children at Risk for Severe Influenza

Top Infectious Disease News Stories Week of October 25-October 31